Form D · Other
True Pharma Strip Inc.
Vancouver, A1 · CIK 0001759706
Offering snapshot reported Dec 15, 2020 · SEC filing
- Reported sold
- $1.23M Offering amount: $2M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 15, 2020 | Initial | $1,226,000 | No comparison | 16 | SEC filing |
| Dec 15, 2020 | Initial | $525,000 | No comparison | 6 | SEC filing |
| Sep 13, 2019 | Initial | $7,000,000 | No comparison | 39 | SEC filing |
| Apr 8, 2019 | Initial | $1,849 | No comparison | 9 | SEC filing |
| Nov 29, 2018 | Amendment | $122,176 | $0vs Nov 26, 2018 | 8 | SEC filing |
| Nov 26, 2018 | Initial | $122,176 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $98.1K
- Finders' fees
- $0
- Form D file number
- 021-383252
CVD Unit consisting of $1,000 principal amount bearing 8% interest maturing on 7/31/ 2021 and 666 cm. sh. purchase wrts. Each CVD converts into cm sh at CAD$1.00 per share. Each wrt is exercisable for 1 cm sh at CAD$1.25 per share until 7/31/2024.
CVD Unit consisting of $1,000 principal amount bearing 8% interest maturing on 7/31/ 2021 and 666 cm. sh. purchase wrts. Each CVD converts into cm sh at CAD$1.00 per share. Each wrt is exercisable for 1 cm sh at CAD$1.25 per share until 7/31/2024.
Ascendant Alternative Strategies, LLC - $69,055 Axiom Capital Management Inc. - $29,000
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Ascendant Alternative Strategies, LLC | 283881 | |
| Axiom Capital Management Inc. | 26580 |
Source: Form D, filed Dec 15, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anton Drescher | Director |
| Ralph Olson | Director |
| Gregg Orr | Executive |
| Jacques Poujade | Director, Executive |
| Dana Rohrabacher | Director |
| Kamlesh Shah | Director |
Issuer details
Industry: Other (See others in industry)
Address:
1383 West 8 Th Avenue
Vancouver, A1, V6H3W4
Vancouver, A1, V6H3W4